- US12428473utility2025Combination Therapies Using Anti-pseudomonas PSL and PCRV Binding Molecules0 cites
- US12391768utility2025Antibodies to Ticagrelor and Methods of Use0 cites
- US12371464utility2025Polypeptides and Uses Thereof0 cites
- US12344664utility2025Antibodies to Amyloid Beta0 cites
- US12209099utility2025Azetidobenzodiazepine Dimers and Conjugates Comprising Them for Use in the Treatment of Cancer0 cites
- US12187774utility2025Heterodimeric Relaxin Fusions and Uses Thereof0 cites
- US12187788utility2025Methods for Treating Atopic Dermatitis and Related Disorders0 cites
- US12178911utility2024Dry Powder Formulations of Thymic Stromal Lymphopoietin (tslp)-binding Antibodies and Methods of Use Thereof0 cites
- US12173050utility2024Rsv-specific Antibodies and Functional Parts Thereof0 cites
- US12121590utility2024Pyrrolobenzodiazepines and Conjugates Thereof0 cites
- US12098191utility2024Antibodies to Amyloid Beta0 cites
- US12076406utility2024Conjugates for Targeting and Clearing Aggregates0 cites
- US11904053utility2024Dry Powder Formulations of Thymic Stromal Lymphopoietin (tslp)-binding Antibodies and Methods of Use Thereof0 cites
- US11897949utility2024Compounds and Methods for Treating Pain0 cites
- US11845782utility2023Relaxin Fusion Polypeptides and Uses Thereof0 cites
- US11834473utility2023Engineered O-glycosylation in Recombinant Polypeptides and Uses Thereof0 cites
- US11827706utility2023Anti-b7-h1 Antibodies for Treating Tumors0 cites
- US11795205utility2023Heterodimeric Relaxin Fusions Polypeptides0 cites
- US11795225utility2023Therapeutic Binding Molecules0 cites
Page 1 of 2Next →